Genotyping is the process of studying DNA sequence to determine genetic constitution in the genotypes of living organisms, such as humans, plants, animals, and microorganisms. Human genotyping helps in determining fatherhood or motherhood. Genotyping of micro-organisms, including viruses and bacteria, helps in prevention of spreading of pathogens by tracking down the origin of outbreak. Traditionally, genotyping was partial due to technological limitations, which means doctors and scientists were able to determine only small fraction of genotype. But, technological advancements in recent years present new avenues in the genotyping process by providing whole-genome genotyping.
The factors that drive the growth of the world genotyping market are decreasing prices of DNA sequencing, increasing incidence of genetic diseases, growing importance of SNP genotyping in drug development, awareness on personalized medicine, and increasing demand for genotyping of animal & plant livestock. However, ambiguity in the reimbursement for these products and a lack of trained professional are factors that restrain the growth of this market. Increasing application areas of genotyping and increasing investments by key manufacturers create opportunities in the market.
The world genotyping market is segmented based on products & services, technology, applications, end users, and geography. The market is further segmented based on products & services into reagents & kits, genotyping services, instruments (sequencer & amplifiers and analyzers), and bioinformatics software. The market is further segmented on the basis of technology into microarrays, capillary electrophoresis (AFLP, RFLP, and SSCP), polymerase chain reaction (PCR) (real-time and digital), sequencing (Next-Generation Sequencing, pyrosequencing, and sanger sequencing), MALDI-TOF, allele specific oligonucleotide (ASO) probes, and others.
The world genotyping market is further categorized based on applications into pharmacogenomics, animal genetics, diagnostic research, agricultural biotechnology, and others. Furthermore, the market is segmented based on end users into pharmaceutical & biopharmaceutical companies, diagnostic & research laboratories, and academic institutes.
The genotyping market is further categorized based on geography into North America, Asia-Pacific, Europe, and Rest of the World (RoW). The North American market is further classified into Canada and U.S. The Asia-Pacific market is further segmented into China, Japan, India, and the Rest of the Asia (RoA). The European region is further divided into France, Italy, Spain, Germany, U.K., and Rest of the Europe (RoE). The Rest of the World includes Middle East & Africa, and Latin America.
The key manufacturers profiled in the report are Affymetrix Inc., Illumina Inc., Sequenom Inc., Thermo Fisher Scientific Inc., Agilent Technologies, QIAGEN N.V., Beckman Coulter, Roche, GE Healthcare, and Fluidigm Corporation. Various strategies such as mergers & acquisitions, expansions, and new product launches are implemented by these manufacturers to gain presence in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
By Products & Services
By End User
SIMILAR MARKET STUDIES
Laser Cutting Flat Bed Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South ...
April 2017 | $2850 | View Details >>
Notes: Sales, means the sales volume of Anti-icing System Revenue, means the sales value of Anti-icing System This report studies sales (consumption) of Anti-icing System in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Clariant ATAGO GVM, Inc. CAV Ice Protection Cox ...
February 2017 | $3800 | View Details >>
This new report from VPGMarketResearch contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including:
June 2015 | $2500 | View Details >>
2015 Germany Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
About This ReportThis new 322-page report from VPGMarketResearch.com presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition ...
October 2015 | $1450 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research